Turner, Mark A. http://orcid.org/0000-0002-5299-8656
Hildebrand, Heidrun
Fernandes, Ricardo M.
de Wildt, Saskia N.
Mahler, Fenna
Hankard, RĂ©gis
Leary, Rebecca
Bonifazi, Fedele
Nobels, Patrick
Cheng, Katharine
Attar, Sabah
Rossi, Paolo
Rocchi, Francesca
Claverol, Joana
Nafria, Begonya http://orcid.org/0000-0002-4494-3663
Giaquinto, Carlo
Funding for this research was provided by:
Innovative Medicines Initiative (777389)
Article History
Accepted: 15 December 2020
First Online: 4 February 2021
Declarations
:
: The Collaborative Network for European Clinical Trials for Children (conect4children or c4c) is an action under the Innovative Medicines Initiative 2 (IMI2) Joint Understanding (ExternalRef removed), Grant Agreement 777389. The open access fee was paid by the University of Liverpool.
: All the authors are associated with the c4c project because their employers are Beneficiaries of the c4c Consortium. Cheng is an employee of Johnson and Johnson; Hildebrand is an employee of Bayer AG.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: MAT drafted the paper and contributes to the leadership of c4c. HH reviewed the paper and contributes to the leadership of c4c. RMF reviewed the paper and contributes to the leadership of c4c. SdW reviewed the paper and contributes to the leadership of c4c. FM reviewed the paper and contributes to the leadership of c4c. RH reviewed the paper and contributes to the leadership of c4c. RL reviewed the paper and contributes to the leadership of c4c. FB reviewed the paper and contributes to the leadership of c4c. PN reviewed the paper and contributes to the leadership of c4c. KC reviewed the paper and contributes to the leadership of c4c. SA reviewed the paper and contributes to the leadership of c4c. PR reviewed the paper and contributes to the leadership of c4c. FR reviewed the paper and contributes to the leadership of c4c. JC reviewed the paper and contributes to the leadership of c4c. BN reviewed the paper and contributes to the leadership of c4c. CG reviewed the paper and contributes to the leadership of c4c.